Fund profile / United States

Bain Capital Life Sciences IV

Geography: United States
Stage: Seed
Fund size: $3000M
Focus: Biotech and SaaS
Signals: Published

N°01 / About

About Bain Capital Life Sciences IV

Bain Capital Life Sciences IV is a venture capital firm based in United States, focusing on Seed stage investments. The fund actively supports founders building innovative solutions in Biotech, SaaS, providing strategic guidance and capital to help startups scale.

N°02 / Thesis

Investment Focus

Location / RegionUnited States

Funding StageSeed

Industry Focus

Biotech

SaaS

Investor Signals Profile

active

Sweet Spot

Operational founder; industrial/tech/healthcare; scale-ready; AI-transformation ready

Growth & Venture

Life Sciences

Healthcare AI

Tech Opportunities

Real Assets & CRE

Decarbonization

Digital Infrastructure

Asia-Pacific Credit

Industrial & Manufacturing

Fiber Broadband

AI-First Transformation

Bullish Signals

Global platform: PE, VC, Credit, Real Assetsexternal

New Abu Dhabi office opened April 2026external

40+ year track record, multi-strategyexternal

Active Life Sciences exits & launchesexternal

Healthcare AI Summit hosted; deep convictionlinkedin

New healthcare PE hire: Michael Horowitztwitter

Australia PE expansion: WealthPerpetual acquisitiontwitter

Active European PE deals: Tingstad investmenttwitter

Tech Opportunities team active post-sellofftwitter

Real Estate team hosts 100-student CRE summitlinkedin

Three record distribution years; strong realizationslinkedin

AI as value-creation lever across portfoliolinkedin

Healthcare AI: CounselHealth, Clover Health investmentstwitter

Aerospace & defense: FDH Aero partnership growthtwitter

Real estate: flex living, asset management focustwitter

Aircraft finance: JB Aircraft Finance LLC launchtwitter

Decarbonization: Ahlstrom, Fedrigoni biomethane leadershiptwitter

Consumer software: XTEL trade promotion carve-outtwitter

Retail: $1B open-air retail platform, 18 assetstwitter

Asia PE VI: $10.5B closed, 20-year regional presencetwitter

Asia-Pac credit: $60T market, only 5% penetratedtwitter

Southeast Asia data centers: 50% capacity growth next 5yrtwitter

OpenAI partnership: Deployment Company AI servicestwitter

Operational discipline replaces macro tailwinds reliancelinkedin

$1.5B Eaton Fiber/Verizon broadband expansion investmenttwitter

Vitabiotics acquisition: UK #1 vitamin brand, 55yr heritagetwitter

SupplyOn investment: 220M+ SME procurement networktwitter

Industrial platform: 140+ investments, $42B deployedtwitter

Europe: €1B invested across Living/Logistics/Digital/Hospitalitytwitter

$42M+ cumulative Pan-Mass Challenge cancer research supportlinkedin

Marine turbomachinery: Global shipping, naval, data center playtwitter

Maria Andrisani: PE News 20 Trailblazing Women 2026 honoreelinkedin

€4bn+ Everllence financing package successfully structuredlinkedin

Women in leadership: Growing ranks visible in top roleslinkedin

Microsoft partnership: European PE CEOs immersion on AIlinkedin

AI-first mindset: Workflow redesign, not tech layeringlinkedin

Internal AI enablement: Portfolio value-creation playbooklinkedin

Cara de Bruyn leading transformation across European PElinkedin

Contrarian Signals

Mega-fund — small checks unlikelyexternal

Complex platform; long decision cyclesexternal

Broad mandate dilutes VC focusexternal

Heavy PE/credit focus; VC secondarytwitter

Macro tailwinds fading; execution now bottlenecklinkedin

Founder Do's

Show seed-to-scale growth potential

Bring deep sector expertise

Align on long-term value creation

Demonstrate sustainability awareness

Leverage cross-platform collaboration fit

Highlight AI-native or AI-transformation angle

Focus on operational excellence & execution

Build trust & consumer brand loyalty

Redesign workflows ground-up, not tech layering

Embed AI-first mindset, not just tool adoption

Founder Don'ts

Avoid short-term exit narratives

Don't ignore ESG/impact angle

No niche without scalable vision

Don't treat AI as technology problem, not mindset shift

78 signals on Bain Capital Life Sciences IV

38 bullish · 5 contrarian · 10 pitch do's · 4 don'ts · 21 GP profiles, each with its source. From €9/month, cancel anytime.

See a signal free View Plans Browse all Signal Profiles →

Facts

Fund Overview

Fund Size$3000M

Saves0

Website

People

Key People

Matthew Calistri, Allyson Rinderle

Chris GordonPartner

Paul MoskowitzPartner

Amrita SankarDirector

Ryan CottonPartner

David GrossPartner

Jennifer Wilson DavisPartner

Darren AbrahamsonPartner

Jonathan LavinePartner

Michael HorowitzPartner

John WrightPartner

Rafael MasonPartner

Marc TouboulPartner

Angelo RufinoPartner

Tom MaughanPartner

Martha KelleyPartner

Andrew SchantzPartner

Cecile BelamanPartner

Drew ChenPartner

Gauthier ReymondierPartner

Maria AndrisaniPartner

Cara de BruynPartner

N°04 / See also

Related Funds

Mangusta Capital Fund I

Fund size$55M

Location: United States
Stage: Seed
Focus: Ai Ml, Vertical Saas, Consumer Commerce, Digital Health, Wellness Lifestyle, Climate Sustainability, Supply Chain, Cybersecurity
Manager: Kevin Jiang

Seed

Ai Ml

Vertical Saas

Consumer Commerce

Digital Health

Wellness Lifestyle

Climate Sustainability

Supply Chain

Cybersecurity

Betaworks Ventures Fund III

Fund size$66M

Location: United States
Stage: Seed
Focus: Ai Ml, Consumer Commerce, Developer Tools
Manager: John Borthwick, Jordan Crook

Seed

Ai Ml

Consumer Commerce

Developer Tools

SemperVirens Core Fund III

Fund size$141M

Location: United States
Stage: Seed
Focus: Saas
Manager: Robby Eters, Greg Golub

Seed

Saas